These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35743091)

  • 1. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time.
    Merzel Šabović EK; Starbek Zorko M; Janić M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.
    Cozzani E; Rosa GM; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and Cardiovascular Risk: A Comprehensive Review.
    Masson W; Lobo M; Molinero G
    Adv Ther; 2020 May; 37(5):2017-2033. PubMed ID: 32314303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.
    Boehncke WH
    Front Immunol; 2018; 9():579. PubMed ID: 29675020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis.
    Wang Y; Zang J; Liu C; Yan Z; Shi D
    Front Immunol; 2022; 13():835671. PubMed ID: 35514987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.
    Piaserico S; Orlando G; Messina F
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.
    Benson MM; Frishman WH
    Cardiol Rev; 2015; 23(6):312-6. PubMed ID: 26440534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of severe plaque psoriasis in patients with cardiovascular disease.
    Piaserico S; Messina F
    Expert Opin Pharmacother; 2022 May; 23(7):853-864. PubMed ID: 35361040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.
    Shlyankevich J; Mehta NN; Krueger JG; Strober B; Gudjonsson JE; Qureshi AA; Tebbey PW; Kimball AB
    Am J Med; 2014 Dec; 127(12):1148-53. PubMed ID: 25149424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
    Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
    Front Immunol; 2018; 9():1234. PubMed ID: 29910818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.